NextPlat Q2 FY26 net loss narrows 92% to $144,000; revenue rises 21% sequentially to $11.9 million

Reuters2026/08/13 12:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

NextPlat posted Q2 revenue of USD 11.9 million, up about 21% sequentially, with gross margin rising to about 40%.
Net loss attributable to common stockholders narrowed about 92% year over year to USD 144,000, or USD 0.05 per share.
Contracted pharmacy revenue more than doubled to about USD 2.2 million, while e-commerce revenue climbed about 27% sequentially to about USD 4.1 million.
CEO David Phipps said results mark an inflection point in the turnaround, driven by a shift toward higher-margin 340B contracted pharmacy services.
Management expects to launch a nationwide medication-fulfillment website in Q3 2026, aiming to expand PharmcoRx beyond Florida.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextPlat Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608130801PR_NEWS_USPR_____FL25621) on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NextPlat Q2 FY26 net loss narrows 92% to $144,000; revenue rises 21% sequentially to $11.9 million

You may also like

Crypto prices